Detalhe da pesquisa
1.
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma.
Ann Hematol
; 100(7): 1755-1767, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625572
2.
Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis.
Eur J Haematol
; 107(1): 129-136, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764578
3.
Atypical chronic myeloid leukaemia: A case of an orphan disease-A multicenter report by the Polish Adult Leukemia Group.
Hematol Oncol
; 2018 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512182
4.
Are myelodysplastic syndromes underdiagnosed in Poland? A report by the Polish Adult Leukaemia Group.
Eur J Haematol
; 98(2): 154-159, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27699872
5.
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma.
Ann Hematol
; 100(7): 1919, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33760951
6.
Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients - results of the PALG study 'PolAZA'.
Hematology
; 26(1): 556-564, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34384334